Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;26(1):e192-e193.
doi: 10.1002/onco.13589. Epub 2020 Nov 23.

In Reply

Sriram Gubbi  1 , Lisa M Cordes  2 , Joanna Klubo-Gwiezdzinska  1 , Ravi A Madan  2 , Lynnette K Nieman  3 , James L Gulley  4 , Jaydira Del Rivero  5
Affiliations
Comment

In Reply

Sriram Gubbi et al. Oncologist. 2021 Jan.

Abstract

This letter to the editor responds to comments by Salinas and colleagues on experiences with identification of adrenal insufficiency among patients on immune checkpoint inhibitor therapy.

PubMed Disclaimer

Comment on

References

    1. Salinas C, Samtani S, Burotto M. Primary adrenal insufficiency due to immune checkpoint inhibitors: More common than we thought. The Oncologist 2020. [Epub ahead of print]. - PMC - PubMed
    1. de Filette J, Andreescu CE, Cools F et al. A systematic review and meta‐analysis of endocrine‐related adverse events associated with immune checkpoint inhibitors. Horm Metab Res 2019;51:145–156. - PubMed
    1. Gubbi S, Hannah‐Shmouni F, Verbalis JG et al. Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation. Best Pract Res Clin Endocrinol Metab 2019;33:101371. - PMC - PubMed
    1. Caturegli P, Di Dalmazi G, Lombardi M et al. Hypophysitis secondary to cytotoxic T‐lymphocyte–associated protein 4 blockade: Insights into pathogenesis from an autopsy series. Am J Pathol 2016;186:3225–3235. - PMC - PubMed
    1. Chang L‐S, Barroso‐Sousa R, Tolaney SM et al. Endocrine toxicity of cancer immunotherapy targeting immune checkpoints. Endocr Rev 2019;40:17–65. - PMC - PubMed

Substances